Bank of New York Mellon Corp Has $12.32 Million Stake in Sotera Health Company (NASDAQ:SHC)

Bank of New York Mellon Corp reduced its stake in Sotera Health Company (NASDAQ:SHC - Free Report) by 35.2% during the first quarter, according to its most recent filing with the SEC. The fund owned 1,056,979 shares of the company's stock after selling 573,757 shares during the quarter. Bank of New York Mellon Corp owned 0.37% of Sotera Health worth $12,324,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Sculptor Capital LP purchased a new stake in Sotera Health in the fourth quarter valued at approximately $68,400,000. Two Seas Capital LP boosted its holdings in Sotera Health by 624.0% in the fourth quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after acquiring an additional 2,496,136 shares in the last quarter. D. E. Shaw & Co. Inc. lifted its position in Sotera Health by 140.8% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,624,750 shares of the company's stock valued at $35,907,000 after buying an additional 1,534,666 shares during the period. Ananym Capital Management LP purchased a new position in Sotera Health during the fourth quarter valued at $13,680,000. Finally, Norges Bank purchased a new position in shares of Sotera Health in the 4th quarter worth about $12,764,000. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Price Performance

Shares of NASDAQ SHC traded up $0.35 during mid-day trading on Tuesday, reaching $11.36. 790,650 shares of the company traded hands, compared to its average volume of 1,232,827. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The company has a debt-to-equity ratio of 5.55, a current ratio of 2.46 and a quick ratio of 2.19. The firm has a market cap of $3.22 billion, a PE ratio of 142.02 and a beta of 1.81. The stock has a fifty day simple moving average of $11.88 and a 200-day simple moving average of $12.17.

Sotera Health (NASDAQ:SHC - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.02. Sotera Health had a net margin of 2.24% and a return on equity of 41.08%. The firm had revenue of $254.52 million for the quarter, compared to analyst estimates of $245.56 million. During the same quarter in the previous year, the business posted $0.13 earnings per share. The firm's quarterly revenue was up 2.6% compared to the same quarter last year. Equities research analysts anticipate that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on SHC. Barclays reduced their target price on Sotera Health from $15.00 to $13.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 24th. Piper Sandler reduced their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Wall Street Zen upgraded Sotera Health from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Finally, The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $14.00 to $17.00 in a report on Monday, May 5th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.